z-logo
open-access-imgOpen Access
An EMT‐related gene signature for the prognosis of human bladder cancer
Author(s) -
Cao Rui,
Yuan Lushun,
Ma Bo,
Wang Gang,
Qiu Wei,
Tian Ye
Publication year - 2020
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.14767
Subject(s) - bladder cancer , nomogram , oncology , gene signature , proportional hazards model , univariate , medicine , epithelial–mesenchymal transition , multivariate analysis , survival analysis , cancer , multivariate statistics , biology , gene , gene expression , metastasis , genetics , mathematics , statistics
The transition from non–muscle‐invasive bladder cancer (NMIBC) to muscle‐invasive bladder cancer (MIBC) is detrimental to bladder cancer (BLCA) patients. Here, we aimed to study the underlying mechanism of the subtype transition. Gene set variation analysis (GSVA) revealed the epithelial‐mesenchymal transition (EMT) signalling pathway with the most positive correlation in this transition. Then, we built a LASSO Cox regression model of an EMT‐related gene signature in BLCA. The patients with high risk scores had significantly worse overall survival (OS) and disease‐free survival (DFS) than those with low risk scores. The EMT‐related gene signature also performed favourably in the accuracy of prognosis and in the subtype survival analysis. Univariate and multivariate Cox regression analyses demonstrated that the EMT‐related gene signature, pathological N stage and age were independent prognostic factors for predicting survival in BLCA patients. Furthermore, the predictive nomogram model was able to effectively predict the outcome of BLCA patients by appropriately stratifying the risk score. In conclusion, we developed a novel EMT‐related gene signature that has tumour‐promoting effects, acts as a negative independent prognostic factor and might facilitate personalized counselling and treatment in BLCA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here